Evidence map›Paper›PMID 29123398›Full record

ArticleInternational journal of nanomedicine2017

Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressing.

João Guilherme B De Marchi, Denise S Jornada, Fernanda K Silva, Ana L Freitas, Alexandre M Fuentefria, Adriana R Pohlmann, Silvia S Guterres

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Use of nanoparticles, a modern means of drug delivery, against cryptosporidiosis.Journal of advanced veterinary and animal research · 2023
    Review
  4. Article
  5. Review
  6. Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine.World journal of microbiology & biotechnology · 2021
    Review
  7. [Clinical application of nose ring drain in severe diabetic foot infection].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2020
    Article
  8. [Application of skin stretching device in repair of diabetic foot wound].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2018
    Article
  9. Anti-International journal of nanomedicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

João Guilherme B De MarchiPharmaceutical Sciences Graduate Program.
Denise S JornadaPharmaceutical Sciences Graduate Program.
Fernanda K SilvaPharmaceutical Sciences Graduate Program.
Ana L FreitasDepartment of Organic Chemistry, Institute of Chemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Alexandre M FuentefriaDepartment of Organic Chemistry, Institute of Chemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Adriana R PohlmannPharmaceutical Sciences Graduate Program.
Silvia S GuterresPharmaceutical Sciences Graduate Program.
Universidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of nanoparticles may be particularly advantageous in treating bacterial infections due to their multiple simultaneous mechanisms of action. Nanoencapsulation is particularly useful for lipophilic drugs. In this scenario, triclosan is considered a good candidate due to its lipophilicity, broad-spectrum activity, and safety. In the present study, we have developed and characterized an antimicrobial suspension of triclosan and α-bisabolol against pathogenic strains that are resistant (

Indexed as

BandagesAnti-Infective Agents, LocalCandida albicansChitosanDrug CombinationsDrug Resistance, BacterialDrug Resistance, FungalEscherichia coliMicrobial Sensitivity TestsMonocyclic SesquiterpenesNanocapsulesPseudomonas aeruginosaSesquiterpenesStaphylococcus aureusTriclosanAnti-Infective Agents, LocalbisabololChitosanDrug CombinationsMonocyclic SesquiterpenesNanocapsulesSesquiterpenesTriclosanantimicrobial effectchitosannanocapsulestriclosanα-bisabolol

Identifiers

PMID29123398
PMCPMC5661849
OpenAlexW2766469927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.